MAM
BHVN

Myriad Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Myriad Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.62M Buy
22,127
+7,727
+54% +$964K 0.36% 32
2021
Q4 		$1.98M Buy
+14,400
New +$1.83M 0.22% 67

Other funds holding BHVN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Myriad Asset Management's BHVN Position: Q1 2022 in Review

Myriad Asset Management increased its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 54% in Q1 2022, buying an estimated $964K and bringing the position to 22,127 shares worth $2.62M. The position accounts for 0.36% of the portfolio, ranked #32.

Myriad Asset Management first reported a position in BHVN in Q4 2021 and has held it in 2 quarters since. 307 funds tracked by Wall St. Rank hold BHVN as of Q1 2022.

  • Myriad Asset Management held 22,127 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $2.62M as of Q1 2022.
  • Myriad Asset Management bought 7,727 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2022, an estimated $964K.
  • Biohaven Pharmaceutical Holding Company Ltd. made up 0.36% of Myriad Asset Management's portfolio in Q1 2022, its #32 holding.
  • Myriad Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2021 and has held it in 2 quarters since.
  • 307 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2022.

Based on Myriad Asset Management's 13F filing for Q1 2022, filed 16 May 2022.